Prenatal exposure to toluene results in abnormal neurogenesis and migration in rat somatosensory cortex

ABSTRACT Toluene inhalant abuse during pregnancy may result in growth-retarded microcephalic newborns who subsequently demonstrate developmental impairment. By using a rat model of

toluene-abuse embryopathy, we studied the effects of prenatal toluene exposure on the generation and migration of cortical neurons. Dams were exposed by gavage to either corn oil or toluene

diluted in corn oil on d 6–21 of gestation. The time of origin of cortical neurons was determined in the mature pups of dams injected with the thymidine analogue 5′-bromodeoxyuridine on 1 d

during the period from d 13–21 of gestation. 5′-Bromodeoxyuridine–labeled neurons were identified by immunohistochemistry in a 400-μm-wide column of somatosensory cortex. The brains of the

toluene-exposed pups had a significant reduction in the number of neurons within each cortical layer (_p_ < 0.001). Depending on the cortical layer, the generation of neurons in the

toluene-exposed pups was delayed by 1 or 2 d. In addition, the brains of the toluene-exposed pups also showed evidence of abnormal neuronal migration. However, there were no differences in

either brain weight or body weight between the control and toluene-exposed pups. These observations suggest that although prenatal toluene exposure results in abnormal neuronal proliferation

and migration, brain weight in the toluene-exposed pups may be preserved by enhanced development of glia or the neuropil. SIMILAR CONTENT BEING VIEWED BY OTHERS DEVELOPMENTAL CHANGES IN

BRAIN STRUCTURE AND FUNCTION FOLLOWING EXPOSURE TO ORAL LSD DURING ADOLESCENCE Article Open access 11 August 2024 COCAINE PERTURBS NEURODEVELOPMENT AND INCREASES NEUROINFLAMMATION IN A

PRENATAL CEREBRAL ORGANOID MODEL Article Open access 26 March 2025 SINGULAR AND SHORT-TERM ANESTHESIA EXPOSURE IN THE DEVELOPING BRAIN INDUCES PERSISTENT NEURONAL CHANGES CONSISTENT WITH

CHRONIC NEURODEGENERATIVE DISEASE Article Open access 11 March 2021 MAIN The intentional inhalation of organic solvents (inhalant abuse) is a common form of substance abuse, and a large

number of abusers are adolescent and young adult women (1, 2). The aromatic hydrocarbon toluene is a component of commonly abused commercial products, and some abusers prefer to expose

themselves to pure toluene (3). The fetus of a pregnant toluene abuser is also exposed to this substance, and several cases of clinical toluene-abuse embryopathy have been reported (4–10).

These growth-retarded microcephalic children have a variety of nonspecific dysmorphic features as well as developmental delay, cerebellar dysfunction, language impairment, and hyperactivity.

To study the neurologic and systemic teratologic effects of this solvent, our laboratory has developed a rat model of toluene-abuse embryopathy (11–13). Pregnant dams were exposed to daily

gavage doses of toluene; their fetuses, examined on E19, demonstrated generalized growth retardation, and biochemical indices of brain development indicated that the forebrain contained

fewer nuclei (lower DNA content). However, these changes were not found to be permanent. Prenatally toluene-exposed pups examined at P21 did not demonstrate differences in systemic growth or

in forebrain DNA content when compared with control animals, suggesting that catch-up growth occurred. Although the rat brain undergoes significant development during the first 3 wk of

postnatal life, neurogenesis within the forebrain is essentially complete before birth with only the dentate granule cells originating after birth, primarily during the first postnatal week

(14). Therefore, although the reduced number of forebrain nuclei secondary to prenatal toluene exposure resolved by P21, it is possible that prenatal toluene exposure results in a permanent

reduction in the number of forebrain neurons and that the catch-up growth was due to enhanced glial development. To help answer this question, the present study was designed to evaluate the

effects of prenatal toluene exposure on development of the cytoarchitecture of the rat cerebral cortex. For this study, neurogenesis was evaluated by labeling dividing neuroblasts on a

specific day of gestation with BrdU (15, 16). In this manner, the effects of prenatal toluene exposure on neuronal proliferation and subsequent migration through the developing cortex could

be assessed. METHODS BREEDING OF ANIMALS. The procedures used in this study were approved by the Animal Use and Care Administrative Advisory Committee of the University of California, Davis.

Animal care and breeding procedures were identical to those used in our previous studies (11–13). Specifically, female Sprague-Dawley rats (160–180 g) were purchased from Simonsen

Laboratories, Inc. (Gilroy, CA) and housed in wire mesh cages in a temperature-controlled room at 22°C and under a 12-h light/dark cycle. The animals were provided with water and a diet

consisting of dextrose, 62%; casein, 24%; corn oil, 8%; mineral mix, 6%; and vitamin mix _ad libitum_ (17, 18). For breeding, male rats obtained from the same vendor were placed with the

females overnight. The presence of copulation plugs the following morning was taken as evidence of successful mating, and that day was designated as E0. EXPOSURE TO TOLUENE. Pregnant dams in

the treatment group were exposed to toluene by gavage administration. From our previous work, we demonstrated that a specific oral dose of toluene will simulate a prolonged inhalation

exposure (19). For these studies, a 650 mg/kg body weight gavage dose of toluene, which simulates a 4162-ppm 3-h inhalation exposure, was used. Analytical grade toluene was dissolved in corn

oil to give a final concentration of 650 mg/mL, and the animals in the treatment group received 1 mL/kg body weight of dosing solution per day on E6–21. Control dams received daily gavage

doses of corn oil, 1 mL/kg body weight. TREATMENT WITH BRDU. During gestation, each dam received a single intraperitoneal injection of BrdU (Sigma Chemical Co.) in normal saline, 50 μg/g

body weight. Four dams, two control and two toluene-treated, received a BrdU injection on one of the 9 d of gestation between E13 and E21. Therefore, a total of 36 dams were used for the

study (18 control and 18 toluene-treated). Developing neurons that are undergoing mitosis at the time of the BrdU injection will incorporate BrdU into their DNA. Cells that continue to

divide will have the BrdU label within their nucleus diluted to background levels. Therefore, neurons that were generated on the day of gestation when the dam received BrdU will be labeled

with BrdU (15, 16). DELIVERY, POSTNATAL CARE, AND PREPARATION OF HISTOLOGICSPECIMENS. The dams were allowed to deliver their pups, and the day of delivery was denoted as P0. The pups were

weaned on P21 at which time they were weighed and then killed by CO2 vapor inhalation. The brains were removed and weighed, and then the brains from two male and two female pups per litter

were submitted for histologic evaluation. The tissue was fixed in methanol:chloroform:glacial acetic acid (6:3:1) for 24 h. After fixation, the brains were embedded in paraffin. Serial

coronal sections 10-μm thick were cut, and sections corresponding to level 8.8 of the atlas of Pellegrino _et al._ (20) were affixed to Superfrost/Plus glass slides (Fisher, Pittsburgh, PA).

To be able to easily identify both BrdU-positive and BrdU-negative neurons within these sections, a double labeling immunohistochemical technique was developed (21). Sections were prepared

to demonstrate immunoreactivity for both BrdU and NeuN (22). Briefly, the sections were treated with anti-BrdU monoclonal mouse antibody (Dako, Carpenteria, CA); anti-NeuN monoclonal mouse

antibody (Dr. R.J. Mullen, Salt Lake City, UT); biotinylated anti-mouse IgG (Vector, Burlingame, CA); avidin-biotin-peroxidase complex (Vector) and 3–3′diaminobenzidine (DAB) substrate for

peroxidase with nickel chloride (Vector) for BrdU staining; and avidin-biotin-alkaline phosphatase (Vector) and alkaline phosphatase substrate Vector-Red (Vector) for NeuN staining.

BrdU-positive neurons demonstrated dark brown to black immunoreactivity within the nucleus together with some red immunoreactivity (NeuN) within the cytoplasm of the soma. BrdU-negative

neurons demonstrated red immunoreactivity within the nucleus and the cytoplasm of the soma. Glia and vascular elements were unstained. MICROSCOPIC ANALYSIS OF SOMATOSENSORY CORTEX

CYTOARCHITECTURE. Cortical cell columns 400-μm wide in somatosensory cortex, region Par 1 as defined by Ziles and Wree (23), were selected for study, and two cortical columns per pup were

examined. Tissue from one control pup from a dam that received BrdU on E13 could not be examined. Therefore, for the entire study, the brains from 143 pups (71 control and 72

toluene-treated) were analyzed. Sections were examined with an Olympus BHT microscope (Tokyo, Japan) fitted with a video camera. Each 400-μm-wide field was digitized with a personal computer

and then analyzed with SigmaScan Pro software (Jandel Scientific, San Rafeal, CA). Cortical laminae II through VI were identified, and the total number of neurons per lamina (NeuN

immunoreactive) together with the total number of BrdU-positive neurons per lamina was counted. A disadvantage of the BrdU labeling method compared with [3H]-thymidine autoradiography is

that it is difficult to discriminate between heavily labeled and lightly labeled cells. Therefore, some second and third generation cells in which the nuclear label has not been diluted

completely to background levels were necessarily counted as BrdU positive. The advantages of BrdU immunohistochemistry are the rapid preparation of tissue specimens (several days rather than

1–3 mo) and the decreased expense with no need for darkroom processing (15). The initial report of the use of BrdU labeling to study the development of cortical cytoarchitecture noted that

a disadvantage of the method was the reduced ability to identify the morphologic type of cell that was BrdU positive (15), but this problem was solved by developing the double labeling

method using both BrdU and NeuN (21). DATA PRESENTATION AND ANALYSIS. Litter size, mean pup weight, and mean brain weight were determined for each of the 36 litters (18 control and 18

toluene-treated). The following values were obtained from each of the nine BrdU injection groups (E13–21) for both the control and toluene-treated animals: number of neurons (NeuN-positive

cells) per cortical column (an index of neuronal packing density), number of neurons (NeuN-positive cells) for each cortical lamina, number of BrdU-positive neurons per cortical column, and

number of BrdU-positive neurons for each cortical lamina. The number of neurons per cortical column and the number of neurons per cortical lamina for each pup analyzed were pooled for the

control group and toluene-treated group. To evaluate the number of neurons generated on a particular day of gestation, the mean of the BrdU-positive neurons counted for each of the eight

pups per BrdU injection group was determined (with the exception of the control E13 group, which included only seven pups). All numeric data are presented as mean ± SD. One-way ANOVA was

used to compare the control and toluene-treated groups. A _p_ value < 0.05 was selected for determining statistical significance. For the statistical analysis of the effects of toluene

treatment on litter size, body weight, and brain weight, the litter was selected as the statistical unit. Because brain tissue from only four pups per litter was processed for

immunohistochemistry, the pup was selected as the statistical unit for the analysis of the effects of toluene treatment on the number of neurons per cortical column and the number of neurons

per cortical lamina. RESULTS Maternal exposure to toluene during d 6–21 of gestation did not affect litter size. Litter size in the control groups was 9.4 ± 2.8 pups, whereas the

toluene-exposed group had 8.2 ± 2.8 pups per litter (_F_1, 34 = 2.61, NS). Prenatal toluene exposure did not affect either body weight or brain weight of the pups evaluated at 21 d of life.

The mean pup weight per litter of the control pups was 42.68 ± 4.72 g, whereas the toluene-exposed group weighed 40.09 ± 4.90 g (_F_1, 34 = 2.03, NS). The mean brain weight per litter of the

control group was 1.27 ± 0.06 g and that of the toluene-exposed group was 1.24 ± 0.06 g (_F_1, 34 = 1.72, NS). Although toluene exposure did not affect litter size or the pup brain and body

weights, prenatal toluene exposure did result in several changes in the cytoarchitecture of somatosensory cortex of the mature pups (Table 1). The total number of neurons in the entire

400-μm-wide cortical column (an index of neuronal packing density) was reduced by 12.6% in the toluene-exposed pups (_p_ < 0.001). This reduction in neuronal packing was present in each

cortical lamina, with the greatest reduction in layer IV (26.8%, _p_ < 0.001). BrdU-labeled neurons were easily identified in all sections examined. Gestational exposure to toluene

resulted in several alterations in neurogenesis and neuronal migration. The cumulative number of BrdU-labeled neurons was substantially reduced in the toluene-exposed pups (Fig. 1). This

reduction was noted in each cortical lamina, with the greatest reduction noted in laminae IV and VI (both 52%, data not shown). Prenatal toluene treatment also affected the timing of

neurogenesis. Depending upon the cortical lamina, the onset of neurogenesis was delayed by 1 to 2 d (Fig. 2). This was most apparent in the deeper layers (V and VI). Despite this delay in

the onset of neurogenesis, prenatal toluene exposure did not prolong the overall course of neuronal generation. In both the control and toluene-treated animals, neurogenesis was

substantially complete by gestational E19. The generation of neurons within somatosensory cortex followed the expected inside-to-outside sequence, with layer VI neurons generated earlier and

layer II-III neurons generated later during the period of E13 to E21 (Fig. 3). Although prenatal toluene exposure did not disturb the overall inside-to-outside gradient of neuronal

generation, in particular the distribution of neurons generated on E15 was affected. In the toluene-treated pups, a substantial number of heterotopic BrdU-positive neurons were found within

the white matter immediately below the column of somatosensory cortex (Fig. 4). By extending the 400-μm-wide column from cortical lamina VI down through the subcortical white matter, the

number of BrdU-positive neurons within the white matter was counted. There were 48.8 ± 27.2 BrdU-labeled neurons within the white matter of the toluene-treated pups _versus_ 16.3 ± 4.7

BrdU-positive neurons in the control group (_F_1, 14 = 11.1, _p_ = 0.005). This pattern was present to a much lesser extent for neurons generated on E17 (3.9 ± 2.7 _versus_ 0.9 ± 1.1;_F_1,

14 = 8.7, _p_ = 0.01) but was not noted on any of the other days. On E14, the opposite pattern was found, with 3.1 ± 1.4 BrdU-positive neurons within the white matter of control animals and

0.9 ± 1.6 BrdU-positive neurons in the toluene-treated pups (_F_1, 14 = 8.4, _p_ = 0.012). DISCUSSION Children with toluene-abuse embryopathy are microcephalic and demonstrate significant

clinical neurodevelopmental handicaps (4–10). This clinical teratologic syndrome shares some features with fetal alcohol syndrome (6), a condition that has been studied extensively both

clinically and experimentally. Although neuropathologic specimens of patients with toluene-abuse embryopathy are not available, brains of patients with fetal alcohol syndrome have been

evaluated, and marked alterations in cortical cytoarchitecture have been noted, including neuronal heterotopia and disrupted laminar organization (24). Although the mature brains of our

toluene-exposed pups were not smaller than those of the control pups, prenatal toluene exposure did result in several abnormalities of cortical cytoarchitecture and neuronal generation.

Previous cytoarchitectural studies of neuronal generation and migration using [3H]-thymidine labeling have demonstrated that prenatal ethanol exposure also disrupts the orderly pattern of

neurogenesis (25–28). As the developmental effects of prenatal ethanol exposure were particularly apparent in somatosensory cortex (26, 29), we selected this region to study the effects of

prenatal toluene exposure on cortical development. When the results of our study are compared with those of experiments designed to examine the effects of prenatal ethanol exposure on

neurogenesis, several differences in the effects of these two developmental toxins are apparent. The present experiment demonstrated that prenatal toluene exposure caused a delay in the

onset of neurogenesis of somatosensory cortex and that the neuronal packing of the mature cortex was reduced. Although prenatal ethanol exposure also resulted in a delay in the onset of

neuronal generation, a late surge in neuronal births was demonstrated (25, 27). In addition, although the normal inside-to-outside (radial) gradient of neuronal generation (14) was apparent

in the toluene-treated animals, prenatal ethanol treatment disrupted this gradient. Specifically, the late surge of neuronal generation seen in the brains of the ethanol-treated pups

resulted in mature neurons that were located aberrantly throughout the deeper laminae of the cortical column rather than in the superficial layers (25, 27). This resulted in a decrease in

the number of neurons in lamina II and an increase in the number of neurons in each of the deeper laminae (25). In subsequent studies, it was demonstrated that prenatal ethanol exposure

resulted in a miniaturization of the brain. The microcephalic brains from ethanol-treated pups had fewer neurons, but there were no difference in either the laminar volumes or neuronal

packing density (29). Although the somatosensory cortex of the brains of the toluene-exposed pups also contained fewer neurons, these brains were not microcephalic. This suggests that brain

size must have been preserved by some compensatory mechanism such as glial hyperplasia or hypertrophy of glia and the neuropil. Such cellular changes have been shown in the brains of rats

exposed to ethanol during certain periods of development. Specifically, in rats exposed to ethanol prenatally, increases in both glial somatic volume and neuropil volume have been

demonstrated (29), whereas postnatal ethanol exposure during the developmental period of the brain growth spurt (30) resulted in a transient astrogliosis (31). Similar to the reduction in

somatosensory cortex neuronal number induced by prenatal toluene exposure seen in the present study, inhalation toluene exposure during P1–28 (100 or 500 ppm for 12 h/d) has been shown in

pups examined on P28 to result in a reduction of the volume of the dentate granule cell layer of the hippocampus, whereas other hippocampal layers were unaffected (32). However, in animals

that were killed on P120, these effects were no longer present, suggesting late postnatal compensatory growth of dentate granule cells (33). In the rat, the dentate granule cells undergo

neurogenesis and postmitotic differentiation during the period of exposure, whereas hippocampal pyramidal cells are relatively mature at the time of birth (14). Dentate granule cells

continue to demonstrate some degree of neurogenesis and morphogenesis throughout the juvenile period (34). These observations together with the results from the present study suggest that,

on a histologic level, the developmental toxicity of toluene is most apparent on neurons that undergo neurogenesis only during the interval of toluene exposure. Few neuronal migrational

abnormalities in somatosensory cortex were demonstrated in the pups exposed prenatally to toluene. Whereas prenatal exposure to ethanol resulted in extensive aberrant migration of

late-generated neurons (15, 25), prenatal toluene exposure resulted in some degree of neuronal heterotopia with excessive BrdU-positive neurons labeled on E15 and E17 found within the white

matter. Neurons labeled on E15 were located within each of the cortical laminae. Therefore, it is difficult to conclude the likely migrational destination of the numerous heterotopic neurons

within the white matter of the E15 toluene-treated pups. Neurons labeled on E17 were generally located in the more superficial cortical laminae. Therefore, the heterotopic neurons within

the white matter of the E17 pups may have resulted from failed neuronal migration to laminae II-III and IV. The greater number of BrdU-positive neurons within the white matter of the E14

control animals was likely due to the overall delay of the onset of neuronal generation in the toluene-treated animals. It has been demonstrated that prenatal exposure to ethanol results in

premature transformation of radial glia into astrocytes (35). This has led to the suggestion that the aberrant migration of the late-generated neurons in brains of rats exposed prenatally to

ethanol is secondary to the premature degradation of radial glial networks (35, 36). However, as prenatal toluene exposure resulted in the development of neuronal heterotopia somewhat

earlier during the period of neurogenesis, another mechanism may underlie this abnormality in neuronal migration. The pathophysiologic mechanisms by which toluene produces developmental

abnormalities in the fetus as well as acute and chronic encephalopathy in abusers and after industrial intoxications are poorly understood. Due to its lipid solubility, this solvent is

rapidly distributed to regions of the brain that have a high lipid content (37); this includes the developing CNS of the fetus (38). Clinically, in patients with chronic toluene

encephalopathy, white matter atrophy, loss of oligodendroglia, and gliosis were noted at autopsy (39). Therefore, toluene may have a direct neurotoxic effect on glia. Experimentally, toluene

has been shown to either increase or decrease levels of specific glial markers, depending on the brain region studied. For example, glial acidic fibrillary protein levels were reduced in

the thalami of adult rats exposed to 1000 ppm toluene for 6 h daily for 3 or 7 d (40), whereas a dose-dependent increase in the glial markers α-enolase, creatine kinase-B, and β-S100

protein, suggesting gliosis, was found particularly in the cerebella of rats exposed to up to 1000 ppm toluene for 8 h/d, 6 d/wk for 16 wk (41). Even though the toluene exposures in the

above studies were administered to mature rats, these results lend support to the suggestion that glial hypertrophy or hyperplasia may compensate for the neuronal loss demonstrated in our

study. Toluene has also been shown to affect neurotransmitter systems and neuroendocrine function, particularly of the hypothalamic-pituitary-adrenocortical axis. For example, adult rats

exposed via inhalation to toluene at 1000 ppm for 6 h/d for 4 d had increased median eminence norepinephrine levels and turnover (42). In another study, toluene administered in drinking

water for 28 d to adult mice resulted in a dose-dependent increase in hypothalamic norepinephrine and vanillylmandelic acid levels along with increased levels of circulating

adrenocorticotropic hormone and corticosterone (43). The toluene-induced increases in adrenocorticotropic hormone and corticosterone are of particular interest. Glucocorticoid receptor gene

expression is first noted in the rat brain after E13 (44), a point during gestation when the animals in our study were exposed to toluene. It has been demonstrated that dexamethasone given

to pregnant dams during late gestation produces a permanent increase in hepatic glucocorticoid receptor gene expression of the adult offspring as well as glucose intolerance (45). In another

investigation, stress paradigms administered to adult rats led to a down-regulation of glucocorticoid receptors in hippocampus and cerebellum (46). Given that toluene exposure leads to

elevated corticosterone levels, it is possible that some of the teratologic effects of toluene are due to a disruption of the maternal hypothalamic-pituitary-adrenocortical axis and an

alteration of the development and function of fetal glucocorticoid receptors. The primary effect of prenatal toluene exposure on the cytoarchitecture of somatosensory cortex is a diffuse

reduction in neuronal number. This change could be due to a reduction in neuronal generation and/or enhanced neuronal apoptosis. These experiments have demonstrated that prenatal toluene

exposure results in a delay and shortening of the period of neuronal generation as well as a reduction in cumulative generation of neurons, both of which could contribute to this reduction

in neuronal number. Further studies of the effects of prenatal toluene exposure on the cellular organization of cortex will need to focus on glial development, the possible role of enhanced

neuronal apoptosis, and the effects of this developmental toxin on other brain regions. As our previous work (12, 13) together with the present study demonstrated that prenatal

toluene-induced generalized growth retardation (including microcephaly) resolved by P21, studies of the developmental effects of postnatal toluene exposure during the period of the brain

growth spurt, the final days of gestation through the second week of postnatal life (30), are also needed to better characterize the teratogenic effects of this abused solvent on the CNS.

ABBREVIATIONS * BrdU: 5′-bromodeoxyuridine * NeuN: neuronal nuclear antigen * E: embryonic day * P: postnatal day REFERENCES * Carroll E 1977 Notes on the epidemiology of inhalants. _NIDA

Res Monogr_ 15: 14–27 CAS  PubMed  Google Scholar  * Padilla E, Padilla A, Morales A 1979 Inhalant, marihuana, and alcohol abuse among barrio children and adolescents. _Int J Addict_ 14:

945–964 Article  CAS  PubMed  Google Scholar  * Comstock EG, Comstock BS 1977 Medical evaluation of inhalant abusers. _NIDA Res Monogr_ 15: 54–80 CAS  PubMed  Google Scholar  * Arnold GL,

Kirby RS, Langendoerfer S, Wilkins-Haug L 1994 Toluene embryopathy: clinical delineation and developmental follow-up. _Pediatrics_ 93: 216–220 CAS  PubMed  Google Scholar  * Goodwin TM 1988

Toluene abuse and renal tubular acidosis in pregnancy. _Obstet Gynecol_ 71: 715–718 CAS  PubMed  Google Scholar  * Hersh JH, Podruch PE, Rogers G, Weisskopf B 1985 Toluene embryopathy. _J

Pediatr_ 106: 922–927 Article  CAS  PubMed  Google Scholar  * Hersh JH 1989 Toluene embryopathy: two new cases. _J Med Genet_ 26: 333–337 Article  CAS  PubMed  PubMed Central  Google Scholar

  * Pearson MA, Hoyme HE, Seaver LH, Rimsza ME 1994 Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. _Pediatrics_ 93: 211–215 CAS  PubMed  Google

Scholar  * Streicher HZ, Gabow PA, Moss AH, Kono D, Kaehny WD 1981 Syndromes of toluene sniffing in adults. _Ann Intern Med_ 94: 758–762 Article  CAS  PubMed  Google Scholar  * Toutant C,

Lippmann S 1979 Fetal solvents syndrome. _Lancet_ 1: 1356 Article  CAS  PubMed  Google Scholar  * Gospe SM Jr, Saeed DB, Zhou SS, Zeman FJ 1994 The effects of high-dose toluene on embryonic

development in the rat. _Pediatr Res_ 36: 811–815 Article  CAS  PubMed  Google Scholar  * Gospe SM Jr, Zhou SS, Saeed DB, Zeman FJ 1996 Development of a rat model of toluene-abuse

embryopathy. _Pediatr Res_ 40: 82–87 Article  PubMed  Google Scholar  * Gospe SM Jr, Zhou SS 1998 Toluene abuse embryopathy: longitudinal neurodevelopmental effects of prenatal exposure to

toluene in rats. _Reprod Toxicol_ 12: 119–126 Article  CAS  PubMed  Google Scholar  * Bayer SA, Altman HJ 1995 Neurogenesis and neuronal migration. In: Paxinos G (ed) _The Rat Nervous

System, 2nd Ed_. Academic Press, San Diego, CA, pp 1041–1078 Google Scholar  * Miller MW, Nowakowski RS 1988 Use of bromodeoxyuridine-immunohistochemistry to examine the proliferation,

migration, and time of origin of cells in the central nervous system. _Brain Res_ 57: 44–52 Article  Google Scholar  * Soriano E, Del Rio J 1991 Simultaneous immunocytochemical visualization

of bromodeoxyuridine and neural tissue antigens. _J Histochem Cytochem_ 39: 255–263 Article  CAS  PubMed  Google Scholar  * Zeman FJ 1968 Effects of maternal protein restriction on the

kidney of the newborn young of rats. _J Nutr_ 94: 111–116 Article  CAS  PubMed  Google Scholar  * Taubeneck MW, Daston GP, Rogers JM, Gershwin ME, Ansari A, Keen CL 1995 Tumor necrosis

factor-α alters maternal and embryonic zinc metabolism and is developmentally toxic in mice. _J Nutr_ 125: 908–919 CAS  PubMed  Google Scholar  * Gospe SM Jr, Al-Bayati MAS 1994 Comparison

of oral and inhalation exposures to toluene. _J Am Coll Toxicol_ 13: 21–32 Article  CAS  Google Scholar  * Pellegrino LJ, Pellegrino AS, Cushman AJ 1979 A Stereotaxic Atlas of the Rat Brain,

2nd Ed. Plenum Press, New York, NY * Zhou SS, Gospe SM Jr 1998 Double labeling of proliferating neurons with anti-BrdU and anti-NeuN: an improved immunohistochemical technique utilizing

microwave irradiation. _J Histotechnol_ 21: 201–204 Article  CAS  Google Scholar  * Mullen RJ, Buck CR, Smith AM 1992 NeuN, a specific nuclear neuronal protein in vertebrates. _Development_

116: 201–211 CAS  PubMed  Google Scholar  * Ziles K, Wree A 1995 Cortex: areal and laminar structure. In: Paxinos G (ed) _The Rat Nervous System, 2nd Ed_. Academic Press, San Diego, CA, pp

649–685 Google Scholar  * Clarren SK 1986 Neuropathology in fetal alcohol syndrome. In: West JR (ed) _Alcohol and Brain Development_. Oxford University Press, New York, NY, pp 158–166 Google

Scholar  * Miller MW 1986 Effects of alcohol on the generation and migration of cerebral cortical neurons. _Science_ 233: 1308–1311 Article  CAS  PubMed  Google Scholar  * Miller MW 1987

Effect of prenatal exposure to alcohol on the distribution and time of origin of corticospinal neurons in the rat. _J Comp Neurol_ 257: 372–382 Article  CAS  PubMed  Google Scholar  * Miller

MW 1988 Effect of prenatal exposure to ethanol on the development of cerebral cortex: I. _Alcohol Clin Exp Res_ 12: 440–449 Article  CAS  PubMed  Google Scholar  * Miller MW 1992 Effects of

prenatal exposure to ethanol on cell proliferation and neuronal migration. In: Miller MW (ed) Development of the Central Nervous System: Effects of Alcohol and Opiates. Wiley-Liss Inc, New

York, NY, pp 47–69 * Miller MW, Potempa G 1990 Numbers of neurons and glia in mature rat somatosensory cortex: effects of prenatal exposure to ethanol. _J Comp Neurol_ 293: 92–102 Article 

CAS  PubMed  Google Scholar  * Dobbing J 1981 The later development of the brain and its vulnerability. In: Davis JA, Dobbing J (eds) _Scientific Foundations of Paediatrics, 2nd Ed_. William

Heinemann Medical Books Ltd, London, pp 744–759 Google Scholar  * Goodlett CR, Leo JT, O'Callaghan JP, Mahoney JC, West JR 1993 Transient cortical astrogliosis induced by alcohol

exposure during the neonatal brain growth spurt in rats. _Dev Brain Res_ 72: 85–97 Article  CAS  Google Scholar  * Slomianka L, Edelfors S, Ravn-Jonsen A, Rungby J, Danscher G, West MJ 1990

The effect of low-level toluene exposure on the developing hippocampal region of the rat: histological evidence and volumetric findings. _Toxicology_ 62: 189–202 Article  CAS  PubMed  Google

Scholar  * Slomianka L, Rungby J, Edelfors S, Ravn-Jonsen A 1992 Late postnatal growth in the dentate area of the rat hippocampus compensates for volumetric changes caused by early

postnatal toluene exposure. _Toxicology_ 74: 203–208 Article  CAS  PubMed  Google Scholar  * Kaplan MS, Bell DH 1983 Neuronal proliferation in the 9-month-old rodent - radioautographic study

of granule cells in the hippocampus. _Exp Brain Res_ 52: 1–5 Article  CAS  PubMed  Google Scholar  * Miller MW, Robertson S 1993 Prenatal exposure to ethanol alters the postnatal

development and transformation of radial glia to astrocytes in the cortex. _J Comp Neurol_ 337: 253–266 Article  CAS  PubMed  Google Scholar  * Guerri C, Renau-Piqueras J 1997 Alcohol,

astroglia, and brain development. _Mol Neurobiol_ 15: 65–81 Article  CAS  PubMed  Google Scholar  * Gospe SM Jr, Calaban MJ 1988 Central nervous system distribution of inhaled toluene. _Fund

Appl Toxicol_ 11: 540–545 Article  CAS  Google Scholar  * Ghantous H, Danielsson BRG 1986 Placental transfer and distribution of toluene, xylene, and benzene, and their metabolites during

gestation in mice. _Bio Res Pregnancy Perinatol_ 7: 98–105 CAS  Google Scholar  * Kornfeld M, Moser AB, Moser HW, Kleinschmidt-Demasters B, Nolte K, Phelps A 1994 Solvent vapor abuse

leukoencephalopathy. _J Neuropathol Exp Neurol_ 53: 389–398 Article  CAS  PubMed  Google Scholar  * Little AR Jr, Gong A, Singh U, El-Fawal H, Evans HL 1998 Decreases in brain glial

fibrillary acidic protein (GFAP) are associated with increased serum corticosterone following inhalation exposure to toluene. _Neurotoxicology_ 19: 739–747 CAS  PubMed  Google Scholar  *

Huang J, Asaeda N, Takeuchi Y, Shibata E, Hisanaga N, Ono J, Kato K 1991 Dose-dependent effects of chronic exposure to toluene on neuronal and glial cell marker proteins in the central

nervous systems of rats. _Br J Ind Med_ 49: 282–286 Google Scholar  * Andersson K, Fuxe K, Toftgård R, Nilsen OG, Eneroth P, Gustafsson JÅ 1980 Toluene-induced activation of certain

hypothalamic and median eminence catecholamine nerve terminal systems of the male rat and its effects on anterior pituitary hormone secretion. _Toxicol Lett_ 5: 393–398 Article  CAS  PubMed

  Google Scholar  * Hsieh GC, Sharma RP, Parker RDR 1991 Hypothalamic-pituitary adrenocortical axis activity and immune function after oral exposure to benzene and toluene.

_Immunopharmacology_ 21: 23–32 Article  CAS  PubMed  Google Scholar  * Kitraki E, Kittas C, Stylianopoulou F 1997 Glucocorticoid receptor gene expression during rat embryogenesis.

_Differentiation_ 62: 21–31 Article  CAS  PubMed  Google Scholar  * Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Secki JR 198 Glucocorticoid exposure in late gestation permanently

programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. _J Clin Invest_ 101: 2174–2181 Article  CAS 

PubMed  PubMed Central  Google Scholar  * Kitraki E, Karandrea D, Kittas C 1998 Long-lasting effects of stress on glucocorticoid receptor gene expression in the rat brain.

_Neuroendocrinology_ 69: 331–338 Article  Google Scholar  Download references ACKNOWLEDGEMENTS The authors thank Dr. M.W. Miller for his assistance with the development of certain histologic

techniques and for critical review of the manuscript and Robert Munn for assisting with digital photomicroscopy. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Departments of Neurology and

Pediatrics, Section of Child Neurology, University of California, Davis, 95616, California, U.S.A. Sidney M Gospe & Shan Shan Zhou Authors * Sidney M Gospe View author publications You

can also search for this author inPubMed Google Scholar * Shan Shan Zhou View author publications You can also search for this author inPubMed Google Scholar ADDITIONAL INFORMATION Supported

in part by Grant R03-DA0665 from the National Institute on Drug Abuse and by funds from the Children's Miracle Network Research Program and the Hibbard E. Williams Research Program,

University of California, Davis. This work was presented at the Annual Meeting of the Pediatric Academic Societies, May 1999, in San Francisco, California. RIGHTS AND PERMISSIONS Reprints

and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Gospe, S., Zhou, S. Prenatal Exposure to Toluene Results in Abnormal Neurogenesis and Migration in Rat Somatosensory Cortex. _Pediatr

Res_ 47, 362–368 (2000). https://doi.org/10.1203/00006450-200003000-00013 Download citation * Received: 28 April 1999 * Accepted: 03 November 1999 * Issue Date: 01 March 2000 * DOI:

https://doi.org/10.1203/00006450-200003000-00013 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is

not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative